Clinical trials
Full profile accessFollow clinical development from trial design and recruitment through results.
- Trial phase
- Status
- Readouts
Company intelligence / Profile preview
Finusolprima Farma Internasional is an Indonesian pharmaceutical company specializing in the production of sterile liquid dosage forms, with a primary focus on large-volume parenterals (LVP) and parenteral nutrition. As a subsidiary of PT Kalbe Farma Tbk, the company operates advanced manufacturing facilities in Cikarang that comply with international Good Manufacturing Practices (GMP). Its product portfolio includes a variety of intravenous fluids, electrolytes, and specialized clinical nutrition products designed for hospital and critical care settings. The company plays a vital role in the Indonesian healthcare supply chain by providing essential infusion therapies for patient recovery and metabolic support.
Beyond the preview
Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.
Follow clinical development from trial design and recruitment through results.
Explore licensing agreements, acquisitions, and the assets behind each deal.
Trace financing activity and the investors behind a company’s development.
Compare peer pipelines by target, modality, and therapeutic area.
Explore technology platforms and the patent landscape around relevant assets.
Connect company news and source material to the questions you’re investigating.
See how Gosset can support your research on Finusolprima Farma Internasional.